Pure Global

Cimosir lupus anticoagulant factor analysis reagent - Taiwan Registration 88caaa598c0ef8855544ea553b4b7ccb

Access comprehensive regulatory information for Cimosir lupus anticoagulant factor analysis reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 88caaa598c0ef8855544ea553b4b7ccb and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
88caaa598c0ef8855544ea553b4b7ccb
Registration Details
Taiwan FDA Registration: 88caaa598c0ef8855544ea553b4b7ccb
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Cimosir lupus anticoagulant factor analysis reagent
TW: ๅธŒๆ‘ฉ่ฅฟ็ˆพ็‹ผ็˜กๆ€งๆŠ—ๅ‡่ก€ๅ› ๅญๅˆ†ๆž่ฉฆๅŠ‘
Risk Class 2

Registration Details

88caaa598c0ef8855544ea553b4b7ccb

DHA00602409901

Company Information

United States

Product Details

HemosIL dRVVT Screen and dRVVT Confirm are qualitative in vitro diagnostic reagents used by diluted Russell's Viper Venom method in IL coagulation system ACL TOP, ACL TOP 500 CTS, ACL ELITE/ELITE PRO 8/9/10000, ACL Advance, ACL Classic ( 100-7000) to analyze lupus anticoagulant factor in citrate acidified human plasma to assess patients for unexplained prolonged APTT.

B Hematology, pathology, and genetics

B.8950 Snake venom reactive agent for Lessell's vipers

import

Dates and Status

Oct 23, 2012

Oct 23, 2027